Optimizing Pharmaceutical Innovation Through AI: A Pathway to Expedited Drug Discovery and Development

Authors

Alberto Coustasse, Marshall UniversityFollow
Craig Kimble, Marshall UniversityFollow
Vinay Penematsa
Thomas Pile, Marshall UniversityFollow

Document Type

Article

Publication Date

5-23-2024

Abstract

Clinical trials are using AI to handle large and complex volumes of categorized and uncategorized data in multi-center clinical trials to develop oncology, cardiovascular, and neurologic compounds and to integrate molecular and imaging data This technology can improve the efficiency of patient recruitment, protocol design, patient monitoring, data analysis, new target discovery, and overall chances that trials will yield valuable data. AI can also detect minute anomalies reducing false negatives in clinical trials, which is especially beneficial with drugs like targeted oncologic agents.

Comments

Copyright © 2024 Pharmacy Times. Reprinted with permission. All rights reserved.

Recommended Citation

Coustasse, A., Kimble, C., Penematsa, V., Pile, T. L. Optimizing Pharmaceutical Innovation Through AI: A Pathway to Expedited Drug Discovery and Development. May 23, 2024. https://www.pharmacytimes.com/view/optimizing-pharmaceutical-innovation-through-ai-a-pathway-to-expedited-drug-discovery-and-development